Total Payments
$310.55
2022 Payments
$78.40
Companies
6
Transactions
18
Medicare Patients
5,053
Medicare Billing
$983,009
Payment Breakdown by Category
Food & Beverage$267.15 (86.0%)
Education$43.40 (14.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $267.15 | 14 | 86.0% |
| Education | $43.40 | 4 | 14.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith+Nephew, Inc. | $113.68 | 6 | $0 (2021) |
| Merck Sharp & Dohme LLC | $91.43 | 6 | $0 (2022) |
| ViiV Healthcare Company | $40.74 | 3 | $0 (2019) |
| ORGANOGENESIS INC. | $25.77 | 1 | $0 (2020) |
| AbbVie Inc. | $23.36 | 1 | $0 (2021) |
| Janssen Biotech, Inc. | $15.57 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $78.40 | 5 | Merck Sharp & Dohme LLC ($78.40) |
| 2021 | $89.21 | 4 | Smith+Nephew, Inc. ($65.85) |
| 2020 | $73.60 | 4 | Smith+Nephew, Inc. ($47.83) |
| 2019 | $15.01 | 1 | ViiV Healthcare Company ($15.01) |
| 2018 | $25.73 | 2 | ViiV Healthcare Company ($25.73) |
| 2017 | $28.60 | 2 | Janssen Biotech, Inc. ($15.57) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/26/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/26/2022 | Merck Sharp & Dohme LLC | ZINPLAVA (Biological) | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/26/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/27/2021 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Other Advanced Wound Management | ||||||
| 06/25/2021 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply), OASIS | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Other Advanced Wound Management | ||||||
| 05/24/2021 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply), OASIS | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Other Advanced Wound Management | ||||||
| 04/05/2021 | AbbVie Inc. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/09/2020 | Smith+Nephew, Inc. | GRAFIX PL (Biological), OASIS | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Other Advanced Wound Management | ||||||
| 07/07/2020 | Smith+Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Pharma Product | ||||||
| 02/20/2020 | ORGANOGENESIS INC. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $25.77 | General |
| Category: Wound Care | ||||||
| 01/27/2020 | Smith+Nephew, Inc. | GRAFIX PL (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Other Advanced Wound Management | ||||||
| 01/17/2019 | ViiV Healthcare Company | JULUCA (Drug), TRIUMEQ | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: HIV | ||||||
| 11/29/2018 | ViiV Healthcare Company | JULUCA (Drug), TRIUMEQ | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: HIV | ||||||
| 08/14/2018 | ViiV Healthcare Company | JULUCA (Drug), TRIUMEQ | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: HIV | ||||||
| 05/10/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug), DIFICID | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/01/2017 | Janssen Biotech, Inc. | PREZCOBIX (Drug), ODEFSEY | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Infectious Diseases & Vaccines | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 1,431 | 4,431 | $1.2M | $290,364 |
| 2022 | 5 | 1,333 | 4,071 | $1.1M | $248,590 |
| 2021 | 5 | 1,246 | 3,695 | $999,270 | $236,751 |
| 2020 | 10 | 1,043 | 3,313 | $842,072 | $207,304 |
Total Patients
5,053
Total Services
15,510
Medicare Billing
$983,009
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 635 | 3,386 | $748,137 | $193,981 | 25.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 610 | 739 | $308,983 | $69,473 | 22.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 173 | 292 | $95,878 | $25,144 | 26.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 14 | $8,671 | $1,766 | 20.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 573 | 3,075 | $679,421 | $157,850 | 23.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 544 | 646 | $270,099 | $62,773 | 23.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 168 | 297 | $97,520 | $21,950 | 22.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 33 | 33 | $20,439 | $4,744 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 20 | $4,400 | $1,272 | 28.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 493 | 2,613 | $577,342 | $137,790 | 23.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 423 | 479 | $200,275 | $47,502 | 23.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 231 | 497 | $163,190 | $37,501 | 23.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 87 | 88 | $54,503 | $12,955 | 23.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 18 | $3,960 | $1,003 | 25.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 326 | 2,033 | $449,191 | $110,833 | 24.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 239 | 267 | $111,635 | $27,517 | 24.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 160 | 321 | $105,400 | $25,058 | 23.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 125 | 129 | $79,896 | $19,523 | 24.4% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Office | 2020 | 51 | 255 | $38,933 | $11,490 | 29.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 111 | $24,420 | $4,331 | 17.7% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2020 | 22 | 70 | $10,688 | $3,125 | 29.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 35 | 35 | $9,158 | $1,964 | 21.4% |
| 11045 | Removal of skin and tissue | Office | 2020 | 12 | 66 | $4,287 | $1,340 | 31.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $4,788 | $1,153 | 24.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 14 | $3,675 | $970.54 | 26.4% |
About Dr. Sohail Ahmed, M.D
Dr. Sohail Ahmed, M.D is a Internal Medicine healthcare provider based in Rockwall, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104866045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sohail Ahmed, M.D has received a total of $310.55 in payments from pharmaceutical and medical device companies, with $78.40 received in 2022. These payments were reported across 18 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($267.15).
As a Medicare-enrolled provider, Ahmed has provided services to 5,053 Medicare beneficiaries, totaling 15,510 services with total Medicare billing of $983,009. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Rockwall, TX
- Active Since 06/08/2006
- Last Updated 06/25/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104866045
Products in Payments
- GRAFIX PL (Medical Supply) $65.85
- JULUCA (Drug) $40.74
- GRAFIX PL (Biological) $36.47
- KEYTRUDA (Biological) $35.00
- Puraply (Medical Supply) $25.77
- DALVANCE (Drug) $23.36
- ZERBAXA (Drug) $21.70
- PREZCOBIX (Drug) $15.57
- NOXAFIL (Drug) $13.03
- Santyl (Drug) $11.36
- DIFICID (Drug) $10.85
- ZINPLAVA (Biological) $10.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rockwall
Carlos Arauz Pacheco, Md, MD
Internal Medicine — Payments: $481,717
Internal Medicine $481,717
Dr. Maria Viqar-Syed, Md, MD
Internal Medicine — Payments: $18,651
Internal Medicine $18,651
Dr. Delano Fabro, D.o, D.O
Internal Medicine — Payments: $11,136
Internal Medicine $11,136
Dr. Nicole Conselman, M.d, M.D
Internal Medicine — Payments: $7,940
Internal Medicine $7,940
Paul Paradiso
Internal Medicine — Payments: $6,872
Internal Medicine $6,872
Dr. Emily Mccullar, M.d, M.D
Internal Medicine — Payments: $5,000
Internal Medicine $5,000